Intellia appoints Michael P. Dube as principal accounting officer

Intellia Therapeutics, Inc.

Michael P. Dube, 46, appointed as principal accounting officer; currently VP and Chief Accounting Officer.
Dube joined Intellia in September 2023; previously Global Corporate Controller at Abiomed (2012-2023).
Dube is a CPA with 10 years at Deloitte & Touche in audit and assurance.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Michael P. Dube

principal accounting officer

NTLA · Intellia Therapeutics, Inc.

Effective: 2024-04-10
Filed: April 15, 2024, 7:59 PM ET

On April 10, 2024, Intellia Therapeutics, Inc. (the “Company” or “Intellia”) appointed Michael P. Dube, 46, as principal accounting officer of the Company.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Michael P. Dube was appointed as principal accounting officer at Intellia Therapeutics, Inc..

Action: appointed
Role: principal accounting officer

Exact text from the filing

On April 10, 2024, Intellia Therapeutics, Inc. (the “Company” or “Intellia”) appointed Michael P. Dube, 46, as principal accounting officer of the Company.

View on SEC.gov

Intellia Therapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0000950170-24-044424

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.